LCM
XERS icon

Landscape Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Landscape Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
15,183
-526
-3% -$3.36K 0.01% 613
2026
Q1 		$91.1K Hold
15,709
– – 0.01% 687
2025
Q4 		$123K Hold
15,709
– – 0.01% 655
2025
Q3 		$128K Hold
15,709
– – 0.01% 572
2025
Q2 		$73.4K Hold
15,709
– – 0.01% 617
2025
Q1 		$86.2K Buy
+15,709
New +$63.4K 0.01% 590
2018
Q4 		– Sell
-57,045
Closed -$1.08M – 999
2018
Q3 		$1.08M Hold
57,045
– – 0.08% 238
2018
Q2 		$1.08M Buy
+57,045
New +$1.11M 0.09% 176

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Landscape Capital Management's XERS Position: Q2 2026 in Review

Landscape Capital Management reduced its Xeris Biopharma Holdings (XERS) stake by 3.3% in Q2 2026, selling an estimated $3.36K and leaving 15,183 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #613.

Landscape Capital Management first reported a position in XERS in Q2 2018 and has held it in 8 quarters since. The position peaked at $1.08M in Q3 2018. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Landscape Capital Management held 15,183 shares of Xeris Biopharma Holdings worth $120K as of Q2 2026.
  • Landscape Capital Management sold 526 Xeris Biopharma Holdings shares in Q2 2026, an estimated $3.36K.
  • Xeris Biopharma Holdings made up 0.01% of Landscape Capital Management's portfolio in Q2 2026, its #613 holding.
  • Landscape Capital Management first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 8 quarters since.
  • Landscape Capital Management's Xeris Biopharma Holdings position peaked at $1.08M in Q3 2018.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.